Clinical Trials Directory

Trials / Completed

CompletedNCT03653793

LivRelief Varicose Veins Cream in the Treatment of Varicose Veins

LivRelief Varicose Veins Cream in the Treatment of Chronic Venous Insufficiency of the Lower Limbs: A 6-week Single Arm Pilot Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Delivra, Inc. · Industry
Sex
All
Age
19 Years
Healthy volunteers
Not accepted

Summary

Phase IV interventional design where all participants used the test product as per package instructions for 6-weeks. Baseline observations were compared to those collected after 6-weeks of treatment.

Detailed description

The use of the marketed natural product, LivRelief Varicose Veins Cream, was observed in 32 patients with lower limb varicose veins. Participants were recruited from the patient population at The Mayer Institute in Hamilton Ontario, Canada. Patients that agreed to participate in the study and met the eligibility criteria were provided with a 6-week supply of the cream to use at home as directed on the product packaging. The following study measures were performed at the clinic prior to the first use of the cream, then again at the clinic after 6 weeks of use: CEAP (Clinical, Etiological, Anatomical, Pathophysiological) classification and VCSS (Venous Clinical Severity score). These are assessments performed by the doctor or nurse to determine the severity of their varicose veins and CVI (chronic venous insufficiency), measurements taken of the circumference of their legs to measure swelling of the legs, photographs of the varicose veins, a quality of life enjoyment and satisfaction questionnaire (QLES-Q-SF) completed by the subjects to describe their satisfaction with various aspects of their life over the last week and documentation of any reactions to the treatment. The cream was applied to their varicose veins twice a day for 6 weeks.

Conditions

Interventions

TypeNameDescription
OTHERNatural Health Product: LivRelief Varicose Veins CreamThis product is intended to improve circulation and blood flow to minimize the appearance of varicose veins.

Timeline

Start date
2017-05-23
Primary completion
2017-08-28
Completion
2017-08-28
First posted
2018-08-31
Last updated
2018-08-31

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03653793. Inclusion in this directory is not an endorsement.